The story
Founded by Ran Poliakine on Dec 2018.1
Overview
Compare with Butterfly Network, Inc., Hologic or GE HealthCare, or pick any stock.
- TickerNNOX on Nasdaq1
- Industrymedical technology industry1
- HeadquartersPetah Tikva1
- Websitewww.nanox.vision
- Incorporated inIsrael5
- Business addressOfer Tech Park, 94 Shlomo Shmeltzer Road, Petach Tikva, L3 49706025
- Filer categoryAccelerated filer5
See how the biggest companies compare on our leaderboards
September 3, 2019 and as amended on December 3, 2019 and December 31, 2019, between Nanox Gibraltar and us.6 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
-98.2%Gross margin4
-600.8%Operating margin4
-576.1%Net margin4
15.4%Revenue growth, 20254
-53.7%Return on equity4
-$45.0MFree cash flow4
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Radiology Services brought in 89% of the revenue Nano-X Imaging broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Radiology Services | $9.5M | $10.3M | $11.6M |
| AISolutions | $327.0K | $727.0K | $958.0K |
| Nanox ARCMember | $116.0K | $281.0K | $478.0K |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue55¢$25.8M
- Research and development41¢$19.2M
- Income tax4¢$1.8M
Out of $13.0M in revenue.4 The company lost money this year.
Financial statements
No quarterly figures reported.
Every line of the income statement as filed: the last 3 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| REVENUE | $13.0M | $11.3M | $9.9M |
| COST OF REVENUE | $25.8M | $21.9M | $16.5M |
| GROSS LOSS | -$12.8M | -$10.6M | -$6.6M |
| Research and development, net | $19.2M | $20.2M | $26.0M |
| Sales and Marketing | $5.7M | $3.4M | $4.2M |
| General and administrative | $21.6M | $22.5M | $24.3M |
| Goodwill impairment | $7.4M | ||
| Change in contingent earnout liability | $7.0K | -$4.5M | |
| Impairment of long-lived assets | $17.5M | ||
| Other expenses (income) | $1.4M | $90.0K | -$1.4M |
| TOTAL OPERATING EXPENSES | $65.4M | $46.1M | $56.0M |
| OPERATING LOSS | -$78.2M | -$56.7M | -$62.6M |
| REALIZED INCOME (LOSS) FROM SALE OF MARKETABLE SECURITIES | $2.0K | -$178.0K | |
| FINANCIAL INCOME, net | $1.4M | $2.9M | $1.7M |
| OPERATING LOSS BEFORE INCOME TAXES | -$76.8M | -$53.9M | -$61.1M |
| INCOME TAX BENEFIT | $1.8M | $358.0K | $339.0K |
| NET LOSS | -$75.0M | -$53.5M | -$60.8M |
| BASIC LOSS PER SHARE (in Dollars per share) | -$1.16 | -$0.91 | -$1.08 |
| DILUTED LOSS PER SHARE (in Dollars per share) | -$1.16 | -$0.91 | -$1.08 |
| WEIGHTED AVERAGE NUMBER OF BASIC ORDINARY SHARES OUTSTANDING (IN THOUSANDS) (in Shares) | 64.8K shares | 58.7K shares | 56.4K shares |
| WEIGHTED AVERAGE NUMBER OF DILUTED ORDINARY SHARES OUTSTANDING (IN THOUSANDS) (in Shares) | 64.8K shares | 58.7K shares | 56.4K shares |
| Reclassification of net losses (income) realized in income statement | -$2.0K | $178.0K | |
| Unrealized gain from marketable securities | $1.0K | $306.0K | $1.5M |
| Total other comprehensive income: | $1.0K | $304.0K | $1.7M |
| TOTAL COMPREHENSIVE LOSS | -$75.0M | -$53.2M | -$59.1M |
No quarter-by-quarter statement was filed.
No quarterly figures reported.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $49.2M | $39.3M | ||
| Short-term deposits | $10.5M | $15.5M | ||
| Marketable securities | $18.4M | |||
| Accounts receivables net of allowance for credit losses of $367 and $112 as of December 31, 2025, and December 31, 2024, respectively. | $2.0M | $1.8M | ||
| Inventories | $3.1M | $1.5M | ||
| Prepaid expenses | $1.3M | $827.0K | ||
| Other current assets | $845.0K | $1.3M | ||
| TOTAL CURRENT ASSETS | $66.8M | $78.7M | ||
| Restricted deposits | $361.0K | $337.0K | ||
| Long-term deposits | $10.0M | |||
| Property and equipment, net | $29.7M | $45.4M | ||
| Goodwill | $316.0K | $7.4M | ||
| Operating lease right-of-use asset | $3.5M | $3.8M | ||
| Intangible assets | $59.9M | $70.0M | ||
| Other non-current assets | $1.6M | $1.8M | ||
| TOTAL NON-CURRENT ASSETS | $95.4M | $131.3M | ||
| TOTAL ASSETS | $162.2M | $210.0M | $218.6M | |
| Short-term loan | $3.1M | $3.1M | ||
| Accounts payable | $2.9M | $2.2M | ||
| Accrued expenses | $4.2M | $4.0M | ||
| Deferred revenue | $534.0K | $140.0K | ||
| Contingent short-term earnout liability | $304.0K | |||
| Current maturities of operating lease liabilities | $950.0K | $745.0K | ||
| Other current liabilities | $4.9M | $3.8M | ||
| TOTAL CURRENT LIABILITIES | $16.9M | $14.0M | ||
| Non-current operating lease liabilities | $3.8M | $3.6M | ||
| Non-current deferred revenue | $17.0K | |||
| Contingent long-term earnout liability | $173.0K | |||
| Deferred tax liability | $600.0K | $2.6M | ||
| Other long-term liabilities | $990.0K | $695.0K | ||
| TOTAL NON-CURRENT LIABILITIES | $5.5M | $6.9M | ||
| TOTAL LIABILITIES | $22.4M | $20.9M | ||
| Ordinary Shares, par value NIS 0.01 per share 100,000,000 authorized at December 31, 2025 and December 31 2024, 69,590,228 and 63,762,001 issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $198.0K | $181.0K | ||
| Additional paid-in capital | $588.3M | $562.7M | ||
| Accumulated other comprehensive loss | -$1.0K | |||
| Accumulated deficit | -$448.8M | -$373.7M | ||
| TOTAL SHAREHOLDERS EQUITY | $139.7M | $189.1M | $195.5M | $216.7M |
| TOTAL LIABILITIES AND SHAREHOLDERS EQUITY | $162.2M | $210.0M | ||
| Accounts receivables net, credit losses | $367.0K | $112.0K | ||
| Ordinary Shares, par value (in New Shekels per share) | 0.01 ILS | 0.01 ILS | ||
| Ordinary shares, shares authorized (in Shares) | 100.0M shares | 100.0M shares | ||
| Ordinary shares, shares issued (in Shares) | 69.6M shares | 63.8M shares | ||
| Ordinary shares, shares outstanding (in Shares) | 69.6M shares | 63.8M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $49.2M | $39.3M | ||
| Short-term deposits | $10.5M | $15.5M | ||
| Marketable securities | $18.4M | |||
| Accounts receivables net of allowance for credit losses of $367 and $112 as of December 31, 2025, and December 31, 2024, respectively. | $2.0M | $1.8M | ||
| Inventories | $3.1M | $1.5M | ||
| Prepaid expenses | $1.3M | $827.0K | ||
| Other current assets | $845.0K | $1.3M | ||
| TOTAL CURRENT ASSETS | $66.8M | $78.7M | ||
| Restricted deposits | $361.0K | $337.0K | ||
| Long-term deposits | $10.0M | |||
| Property and equipment, net | $29.7M | $45.4M | ||
| Goodwill | $316.0K | $7.4M | ||
| Operating lease right-of-use asset | $3.5M | $3.8M | ||
| Intangible assets | $59.9M | $70.0M | ||
| Other non-current assets | $1.6M | $1.8M | ||
| TOTAL NON-CURRENT ASSETS | $95.4M | $131.3M | ||
| TOTAL ASSETS | $162.2M | $210.0M | $218.6M | |
| Short-term loan | $3.1M | $3.1M | ||
| Accounts payable | $2.9M | $2.2M | ||
| Accrued expenses | $4.2M | $4.0M | ||
| Deferred revenue | $534.0K | $140.0K | ||
| Contingent short-term earnout liability | $304.0K | |||
| Current maturities of operating lease liabilities | $950.0K | $745.0K | ||
| Other current liabilities | $4.9M | $3.8M | ||
| TOTAL CURRENT LIABILITIES | $16.9M | $14.0M | ||
| Non-current operating lease liabilities | $3.8M | $3.6M | ||
| Non-current deferred revenue | $17.0K | |||
| Contingent long-term earnout liability | $173.0K | |||
| Deferred tax liability | $600.0K | $2.6M | ||
| Other long-term liabilities | $990.0K | $695.0K | ||
| TOTAL NON-CURRENT LIABILITIES | $5.5M | $6.9M | ||
| TOTAL LIABILITIES | $22.4M | $20.9M | ||
| Ordinary Shares, par value NIS 0.01 per share 100,000,000 authorized at December 31, 2025 and December 31 2024, 69,590,228 and 63,762,001 issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $198.0K | $181.0K | ||
| Additional paid-in capital | $588.3M | $562.7M | ||
| Accumulated other comprehensive loss | -$1.0K | |||
| Accumulated deficit | -$448.8M | -$373.7M | ||
| TOTAL SHAREHOLDERS EQUITY | $139.7M | $189.1M | $195.5M | $216.7M |
| TOTAL LIABILITIES AND SHAREHOLDERS EQUITY | $162.2M | $210.0M | ||
| Accounts receivables net, credit losses | $367.0K | $112.0K | ||
| Ordinary Shares, par value (in New Shekels per share) | 0.01 ILS | 0.01 ILS | ||
| Ordinary shares, shares authorized (in Shares) | 100.0M shares | 100.0M shares | ||
| Ordinary shares, shares issued (in Shares) | 69.6M shares | 63.8M shares | ||
| Ordinary shares, shares outstanding (in Shares) | 69.6M shares | 63.8M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net loss for the year | -$75.0M | -$53.5M | -$60.8M |
| Share-based compensation | $4.2M | $7.3M | $6.8M |
| Amortization of intangible assets | $10.5M | $10.6M | $10.6M |
| Impairment of long-lived assets | $17.5M | ||
| Impairment of goodwill | $7.4M | ||
| Change in contingent earnout liability | $7.0K | -$4.5M | |
| Depreciation | $1.2M | $1.1M | $1.2M |
| Deferred tax liability, net | -$2.0M | -$377.0K | -$377.0K |
| Realized loss (income) from sale of marketable securities | -$2.0K | $178.0K | |
| Exchange rate differentials | $153.0K | -$512.0K | $69.0K |
| Amortization of premium, discount and accrued interest on marketable securities | $108.0K | -$260.0K | $735.0K |
| Interest of short-term deposits | -$459.0K | ||
| Loss from disposal of property and equipment | $207.0K | $202.0K | $1.3M |
| Change in inventories | -$325.0K | -$277.0K | |
| Accounts receivable, net | $107.0K | -$321.0K | -$507.0K |
| Prepaid expenses and other current assets | $409.0K | $190.0K | $1.9M |
| Other non-current assets | $29.0K | $218.0K | -$251.0K |
| Accounts payable | $288.0K | -$1.3M | -$153.0K |
| Accrued expenses and other liabilities | $1.2M | $490.0K | -$9.0M |
| Operating lease assets and liabilities | $655.0K | $209.0K | $352.0K |
| Deferred revenue | $130.0K | -$403.0K | -$37.0K |
| Other long-term liabilities | $295.0K | $83.0K | $129.0K |
| Net cash used in operating activities | -$40.8M | -$36.6M | -$44.8M |
| Release of (investment in) restricted deposits | $46.0K | -$373.0K | |
| Cash paid for business combinations (see note 3) | -$200.0K | ||
| Proceeds from maturity of marketable securities | $18.3M | $41.2M | $38.3M |
| Purchase of marketable securities | -$33.0M | ||
| Proceeds from sale of marketable securities | $822.0K | ||
| Investment in short-term deposits | -$15.5M | ||
| Maturity of short-term deposits | $15.5M | ||
| Investment in long-term deposits | -$10.0M | ||
| Investment in SAFE | -$15.0K | ||
| Purchase of property and equipment | -$4.2M | -$2.8M | -$3.3M |
| Net cash provided by (used in) investing activities | $29.4M | -$20.1M | $35.4M |
| Proceeds from issuance of ordinary shares and warrants, net of issuance costs | $21.2M | $37.8M | $27.1M |
| Payment due to settlement of contingent earnout liabilities | -$790.0K | ||
| Proceeds from issuance of ordinary shares upon exercise of options | $163.0K | $1.7M | $903.0K |
| Net cash provided by financing activities | $21.4M | $39.5M | $27.3M |
| EFFECT OF CHANGES IN EXCHANGE RATES ON CASH AND CASH EQUIVALENTS | -$101.0K | $72.0K | -$60.0K |
| NET CHANGE IN CASH AND CASH EQUIVALENTS | $9.8M | -$17.1M | $17.8M |
| Cash paid for income taxes | $184.0K | $53.0K | $3.0K |
| Cash paid for interest | $132.0K | $140.0K | $149.0K |
| Contingent earnout liability recognized in connection with a business combination | $470.0K | ||
| Issuance of ordinary shares in connection with earnout liability | $1.6M | ||
| Reclassification of earn-out liability to equity | $1.5M | ||
| Non-cash purchase of property and equipment | $74.0K | $223.0K | |
| Operating lease liabilities arising from obtaining operating right-of use assets | $131.0K | $4.4M |
No quarter-by-quarter statement was filed.
Leadership
Who has led Nano-X Imaging, and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
20202025
- FounderRan Poliakine1
- Chief executive officerErez Meltzer Mar 18, 2026 to now12
- Chief financial officerGuy Nathansohn Aug 3, 2026 to now13
- Chief financial officerRan Bendaniel Sep 5, 2025 to Aug 3, 202614
Board members and other officers (12)
- EVP & Chief Marketing OfficerCohen Tamar Aharon Mar 18, 2026 to now15
- GM Source & Services DivisionJames Dara Mar 18, 2026 to now16
- General Manager, ARC DivisionOfir Koren Mar 18, 2026 to now17
- General Manager AI DivisionSharon Saban Apr 7, 2026 to now18
- Chief Corporate ResourcesAttias Gali Yahav Apr 9, 2026 to now19
- Board memberErez Meltzer Mar 18, 2026 to now12
- Board memberMichael Jackman Mar 18, 2026 to now20
- Board memberNoga Kainan Mar 19, 2026 to now21
- Board memberNehama Ronen Mar 24, 2026 to now22
- Board memberErez Alroy Apr 7, 2026 to now23
- Board memberDan S. Suesskind Apr 30, 2026 to now24
- General counselFeler Marina Gofman Mar 18, 2026 to now25
Timeline
Filings
153 filings to the SEC since October 2021: 5 annual reports, 32 insider forms, 13 large holders, 103 other. The latest 20:
- Oct 14, 20264 EDGAR
- Oct 14, 20264 EDGAR
- Oct 14, 20264 EDGAR
- Oct 14, 20264 EDGAR
- Oct 13, 20264 OWNERSHIP DOCUMENT EDGAR
- Oct 13, 20264 EDGAR
- Oct 13, 20264 EDGAR
- Oct 2, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Sep 29, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Sep 17, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Sep 16, 20264 EDGAR
- Sep 15, 20264 EDGAR
- Sep 14, 20264 EDGAR
- Sep 9, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Aug 18, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Aug 13, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Aug 11, 20264 EDGAR
- Aug 7, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Aug 7, 2026424B5 PROSPECTUS SUPPLEMENT EDGAR
- Aug 6, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
The 153 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
9 open-market trades by officers, directors and large owners since October 2021: 8 buys and 1 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Meltzer ErezChief Executive Officer | Buy | 10,000 | $0.69 | $6.9K | Form 4 |
| Sep 14, 2026 | Suesskind Dan SDirector | Buy | 60,000 | $0.76 | $45.3K | Form 4 |
| Sep 10, 2026 | Meltzer ErezChief Executive Officer | Buy | 10,000 | $0.78 | $7.8K | Form 4 |
| Aug 10, 2026 | Meltzer ErezChief Executive Officer | Buy | 9,443 | $1.03 | $9.7K | Form 4 |
| Jul 28, 2026 | Kainan NogaDirector | Buy | 33,000 | $0.90 | $29.7K | Form 4 |
| Jul 27, 2026 | Suesskind Dan SDirector | Buy | 50,000 | $0.93 | $46.5K | Form 4 |
| Jul 27, 2026 | Meltzer ErezChief Executive Officer | Buy | 36,000 | $0.93 | $33.5K | Form 4 |
| Jun 10, 2026 | Alroy ErezDirector | Sale | 678 | $1.65 | $1.1K | Form 4 |
| Sep 5, 2025 | Daniel RanCFO | Buy | 1,000 | $3.65 | $3.6K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- BlackRockSCHEDULE 13G/A, 3 filings Oct 24, 2024 to Jul 29, 202626
- Moshe MoalemSCHEDULE 13G/A, 2 filings Dec 21, 2021 to Jul 15, 202627
- SK square Co LtdSCHEDULE 13G/A, 2 filings Feb 14, 2022 to May 15, 202628
- Ran PoliakineSC 13G/A, 2 filings Feb 14, 2022 to Feb 14, 202329
- Richard B. StoneSC 13G/A, 1 filing Feb 14, 202230
Links
- Websitewww.nanox.vision1
- X (Twitter)x.com/nanox_vision1
- Facebookwww.facebook.com/NanoxVision1
- YouTubewww.youtube.com/channel/UCh99MO560A1QRSO8FDaS4Xw1
- LinkedInwww.linkedin.com/company/nanox-imaging1
- WikidataQ109648854
- SEC EDGARCIK 1795251
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataNano-X Imaging on Wikidata
- 2SEC EDGARNano-X Imaging filings on SEC EDGAR
- 3Company websiteNano-X Imaging logo
- 4SEC EDGARNano-X Imaging 10-K for fiscal 2025
- 5SEC EDGARNano-X Imaging filings on SEC EDGAR
- 6
- 7SEC EDGARNano-X Imaging 10-K for fiscal 2021
- 8SEC EDGARNano-X Imaging 10-K for fiscal 2022
- 9SEC EDGARNano-X Imaging 10-K for fiscal 2018
- 10SEC EDGARNano-X Imaging 10-K for fiscal 2019
- 11SEC EDGARNano-X Imaging 10-K for fiscal 2020
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20SEC EDGARMichael Jackman, Board member
- 21SEC EDGARNoga Kainan, Board member
- 22SEC EDGARNehama Ronen, Board member
- 23SEC EDGARErez Alroy, Board member
- 24SEC EDGARDan S. Suesskind, Board member
- 25SEC EDGARFeler Marina Gofman, General counsel
- 26
- 27
- 28
- 29
- 30